Nasal Spray For Arthritis Planned

Scientists are developing a gene therapy treatment for rheumatoid arthritis (RA) that will come in the form of a nasal spray. Research is still at the laboratory stage, but the team at King's College, London, hope to start clinical trials within three years. The spray would contain a gene that controls production of a natural anti-inflammatory substance. RA is a joint condition that affects around 350,000 people in the UK. Preliminary tests by the King's team suggest nasal drops or a spray would be an effective way to deliver a shot of the key compound - called Interleukin-10.